Need for validation of growth and development assessment test for children under five years of age in Peru
DOI:
https://doi.org/10.59594/iicqp.2023.v1n1.18Abstract
The implementation of neurodevelopmental assessment during routine pediatric visits may significantly reduce the risk of long-term cognitive impairment. Therefore, it is essential that healthcare professionals are able to identify early warning signs of atypical neurological development. These include generalized hypertonia or hypotonia, hyperexcitability syndromes, and the presence of uncoordinated or age-inappropriate movements. Neurodevelopmental assessment is particularly important given that approximately 80% of neurodevelopment occurs within the first three years of life, while language and communication skills continue to develop between three and six years of age. Neurodevelopmental disorders in children under five years are more frequently reported in low- and middle-income countries and are associated with adverse social, motor, economic, academic, and cultural outcomes. For these reasons, neurodevelopmental assessment should be considered a priority in pediatric care.
Downloads
References
Romo-Pardo B, Liendo-Vallejos S, Vargas-López G, Rizzoli-Córdoba A, Buenrostro-Márquez G. Pruebas de tamizaje de neurodesarrollo global para niños menores de 5 años de edad validadas en Estados Unidos y Latinoamérica: revisión sistemática y análisis comparativo. Bol Med Hosp Infant Mex. 2012;69(6):450-62.
Medina Alva MDP, Caro-Kahn I, Muñoz Huerta P, Leyva Sánchez J, Moreno Calixto J, Vega Sánchez SM. Neurodesarrollo infantil: características normales y signos de alarma en el niño menor de cinco años. Rev Peru Med Exp Salud Publica. 2015;32(3):565-73. doi:10.17843/rpmesp.2015.323.1693
Recinos Hidalgo A. Caracterización del neurodesarrollo infantil. “Signos de alarma”. Rev Acad CUNZAC. 2022;2(2):139-49.doi: 10.46780/sociedadcunzac.v2i2.38
Gutierrez L, Lazarte F, Alarcon G. La importancia de la evaluación del neurodesarrollo en niños menores de treinta meses en el contexto peruano. Acta Med Peru. 2017;33(4):304. doi:10.35663/amp.2016.334.224
Isquith-Dicker LN, Kwist A, Black D, Hawes SE, Slyker J, Bergquist S, et al. Early Child Development Assessments and Their Associations with Long-Term Academic and Economic Outcomes: A Systematic Review. Int J Environ Res Public Health. 2021;18(4):1538. doi: 10.3390/ijerph18041538
Ministerio de Salud del Perú. NTS N° 137-MINSA/2017/DGIESP: Norma Técnica de Salud para el Control del Crecimiento y Desarrollo de la Niña y el Niño Menores de Cinco Años [Internet]. Lima: MINSA; 2017 [citado el 29 de marzo de 2023]. Disponible en: https://www.saludarequipa.gob.pe/archivos/cred/NORMATIVA%20CRED.pdf
Sabanathan S, Wills B, Gladstone M. Child development assessment tools in low-income and middle-income countries: how can we use them more appropriately? Arch Dis Child. 2015;100(5):482-8. doi:10.1136/archdischild-2014-308114
Ministerio de Salud del Perú. EEDP. Escala de evaluación del desarrollo psicomotor de 0 - 24 meses[Internet]. Lima: MINSA; 1995 [citado el 29 de marzo de 2023]. Disponible en: http://bvs.minsa.gob.pe/local/minsa/2333.PDF
Ministerio de Salud del Perú. TEPSI. Test de desarrollo psicomotor 2 - 5 años. [Internet]. Lima: MINSA; 1995 [citado el 29 de marzo de 2023]. Disponible en: https://cdn.www.gob.pe/uploads/document/file/342585/TEPSI__Test_de_desarrollo_psicomotor._Dos_a_cinco_a%C3%B1os_20190716-19467-rnxsnn.pdf
Frankenburg WK. Denver Ii: Training Manual. 2nd ed. Denver: Denver Developmental Materials; 1992.
Carvajal A, Centeno C, Watson R, Martínez M, Sanz Rubiales Á. ¿Cómo validar un instrumento de medida de la salud? An Sist Sanit Navar. 2011;34(1):63-72.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.

